Mural Oncology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Mural Oncology and buy or sell other stocks, ETFs, and their options commission-free!About MURA
Mural Oncology Plc is a clinical-stage oncology company, which focuses on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. Its lead product candidate is the Nemvaleukin Alfa which is an interleukin-2 cytokine designed to capture and expand therapeutic benefits of high-dose recombinant human IL-2.
CEOOwen Patrick Hughes, Jr.
CEOOwen Patrick Hughes, Jr.
Employees116
Employees116
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2017
Founded2017
Employees116
Employees116
MURA Key Statistics
Market cap35.34M
Market cap35.34M
Price-Earnings ratio-0.29
Price-Earnings ratio-0.29
Dividend yield—
Dividend yield—
Average volume12.78K
Average volume12.78K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$4.74
52 Week high$4.74
52 Week low$0.95
52 Week low$0.95
Stock Snapshot
As of today, Mural Oncology(MURA) shares are valued at $2.04. The company's market cap stands at 35.34M, with a P/E ratio of -0.29.
On 2025-12-18, Mural Oncology(MURA) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Mural Oncology(MURA) stock has reached 0, versus its average volume of 12.78K.
Over the past 52 weeks, Mural Oncology(MURA) stock has traded between a high of $4.74 and a low of $0.95.
Over the past 52 weeks, Mural Oncology(MURA) stock has traded between a high of $4.74 and a low of $0.95.
People also own
Based on the portfolios of people who own MURA. This list is generated using Robinhood data, and it’s not a recommendation.